LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial
about
A safety and feasibility study of an allogeneic colon cancer cell vaccine administered with a granulocyte-macrophage colony stimulating factor-producing bystander cell line in patients with metastatic colorectal cancer.Tecemotide: an antigen-specific cancer immunotherapy.Recent progress in peptide vaccination in cancer with a focus on non-small-cell lung cancer.Up to 15-year clinical follow-up of a pilot Phase III immunotherapy study in stage II breast cancer patients using oxidized mannan-MUC1.Translational nanoparticle engineering for cancer vaccines.
P2860
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
LICC: L-BLP25 in patients with ...... double-blinded phase II trial
@ast
LICC: L-BLP25 in patients with ...... double-blinded phase II trial
@en
LICC: L-BLP25 in patients with ...... double-blinded phase II trial
@en-gb
LICC: L-BLP25 in patients with ...... double-blinded phase II trial
@nl
type
label
LICC: L-BLP25 in patients with ...... double-blinded phase II trial
@ast
LICC: L-BLP25 in patients with ...... double-blinded phase II trial
@en
LICC: L-BLP25 in patients with ...... double-blinded phase II trial
@en-gb
LICC: L-BLP25 in patients with ...... double-blinded phase II trial
@nl
prefLabel
LICC: L-BLP25 in patients with ...... double-blinded phase II trial
@ast
LICC: L-BLP25 in patients with ...... double-blinded phase II trial
@en
LICC: L-BLP25 in patients with ...... double-blinded phase II trial
@en-gb
LICC: L-BLP25 in patients with ...... double-blinded phase II trial
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
LICC: L-BLP25 in patients with ...... double-blinded phase II trial
@en
P2093
Bernhard Linz
Carl Christoph Schimanski
Daniel Seehofer
Eric van Cutsem
Frank Kullmann
Friedrich Overkamp
Ines Gockel
Jan Schröder
Markus Möhler
Matthias Vöhringer
P2860
P2888
P356
10.1186/1471-2407-12-144
P407
P50
P577
2012-01-01T00:00:00Z
P5875
P6179
1048159736